Home Equities Score What is behind AzurRxBioPharma, Inc.'s (AZRX) recent rise in stock price

What is behind AzurRxBioPharma, Inc.’s (AZRX) recent rise in stock price

AzurRx BioPharma, Inc. (NASDAQ: AZRX), the stock was trending lower -16.4% to $1.65 in the pre-opening session.AZRX stock’s performance has improved over the past few months, evident in Tuesday’s stock price gain. Using several metrics, we can gauge the stock’s performance this year. In the 52 weeks ending today, the high price of AZRX was $2.63, which is 24.33 percent higher than the stock’s current price. However, the current price of AZRX is higher than its 52-week low of $0.37.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

New Development


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Two additional new sites in Poland have been activated for the Expansion arm of Phase 2b OPTION 2 study investigating immediate-release capsules of MS1819 to treat exocrine pancreatic insufficiency in patients with cystic fibrosis (CF).

Read More

During the ongoing COVID-19 pandemic, additional sites were added across Europe to minimize any possible patient enrollment delays. In Poland and the United States, active clinical trial sites are enrolling patients, and the Company expects to report topline data in the first quarter of 2021.

The OPTION 2 clinical trial is a Phase 2b open-label crossover study designed to explore the safety, tolerability, and efficacy of MS1819 vis-à-vis the current standard of care, porcine pancreatic enzyme replacement therapy pills. Primary efficacy endpoints include the coefficient of fat absorption (CFA).

MS1819 will be tested with immediate-release capsules in OPTION 2 Phase 2b trial to find out what the optimal dose and delivery method for MS1819 should be. Patients 18 years of age or older will be included in the extension arm if they have completed OPTION 2 crossover at a higher dose level than OPTION 1. Newly dosed expansion arm participants will be treated for two weeks.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

Finally…

If someone is considering buying this stock, you should take note that analysts at four brokerage firms rate AzurRxBioPharma Inc. (AZRX) at a consensus value of 2.20. Precisely, 3 of the Wall Street analysts polled rate the stock as a buy, the other 1 believes investors should hold the stock, and no analyst gives the stock a “Sell.”

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Invitae Corporation Inc. (NVTA) stock surge during current market. Here’s the update:

Invitae Corporation Inc. (NASDAQ: NVTA) stock gains by 12.35% in the current market trading session. Invitae Corporation is a prominent medical genetics business whose...

Related News

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Invitae Corporation Inc. (NVTA) stock surge during current market. Here’s the update:

Invitae Corporation Inc. (NASDAQ: NVTA) stock gains by 12.35% in the current market trading session. Invitae Corporation is a prominent medical genetics business whose...

Alto Ingredients Inc. (ALTO) stock fall during pre-market trading. Here’s what you should know?

Alto Ingredients Inc. (NASDAQ: ALTO) stock gained by 5.99% at last close whereas the ALTO stock-price plunge by 9.89% in the pre-market trading session....

Cuentas Inc. (CUEN) stock rises during after-hour trading, given no current update.

Cuentas Inc. (NASDAQ: CUEN) stock declined by 4.68% at last close whereas the CUEN stock price gains by 2.6% in the after-market. Cuentas is...

Why did Applied DNA Sciences Inc. (APDN) stock face headwinds in the after-hours on Tuesday?

Applied DNA Sciences Inc. (APDN) shares lost 3.82% in after-hours on Tuesday, August 03, 2021, and closed the daily trading at $6.55 per share....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam